retatrutide micro dosing Guide: 1-12 mg Weekly Triple Agonist (2026) Retatrutide Dosing: What You Need

Effects of dapagliflozin compared with sitagliptin and metformin in drug-nave Japanese patients with type 2 diabetes: A 12-week, open-label, randomized, active-controlled trial

These observations seem to confirm not only the metabolic but also the immunoregulatory effects of these new antidiabetic agents

Lastly, optimum levels of purine metabolites have been associated with the dynamics of clinical symptoms and therapeutic improvements, which may lead to discovery of novel targets for drug development

The FDA-approved formulations for weight loss are semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound)

N.XiongQ.MillerG.PettegrewJ

The Bottom Line A GLP-1 weight loss plateau is common, frustrating, and almost always explainable